High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trialResearch in context

Summary: Background: Vitamin D insufficiency is associated with risk of multiple sclerosis (MS) relapse; whether supplementation influences prognosis is unknown. The Vitamin D to Ameliorate MS (VIDAMS) trial aimed to determine if high dose (5000 International Units (IU)/day) versus low dose (600 IU...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sandra D. Cassard, Kathryn C. Fitzgerald, Peiqing Qian, Susan A. Emrich, Christina J. Azevedo, Andrew D. Goodman, Elizabeth A. Sugar, Daniel Pelletier, Emmanuelle Waubant, Ellen M. Mowry
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-05-01
סדרה:	EClinicalMedicine
נושאים:	Relapsing-remitting multiple sclerosis Vitamin D supplementation Disease activity
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2589537023001347
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!